HEADER LIGASE 30-AUG-07 2JUJ TITLE SOLUTION STRUCTURE OF THE UBA DOMAIN FROM C-CBL COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE CBL; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UBA DOMAIN; COMPND 5 SYNONYM: C-CBL, SIGNAL TRANSDUCTION PROTEIN CBL, PROTO-ONCOGENE C- COMPND 6 CBL, CASITAS B-LINEAGE LYMPHOMA PROTO-ONCOGENE, RING FINGER PROTEIN COMPND 7 55; COMPND 8 EC: 6.3.2.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 GENE: CBL, CBL2, RNF55; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET-32M KEYWDS ALPHA HELIX, UBA DOMAIN, CALCIUM, CYTOPLASM, LIGASE, METAL-BINDING, KEYWDS 2 PHOSPHORYLATION, PROTO-ONCOGENE, SH2 DOMAIN, UBL CONJUGATION KEYWDS 3 PATHWAY, ZINC, ZINC-FINGER EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR Z.R.ZHOU,J.HONG,D.H.LIN,H.Y.HU REVDAT 4 29-MAY-24 2JUJ 1 REMARK REVDAT 3 16-MAR-22 2JUJ 1 REMARK REVDAT 2 24-FEB-09 2JUJ 1 VERSN REVDAT 1 15-JUL-08 2JUJ 0 JRNL AUTH Z.R.ZHOU,H.C.GAO,C.J.ZHOU,Y.G.CHANG,J.HONG,A.X.SONG,D.H.LIN, JRNL AUTH 2 H.Y.HU JRNL TITL DIFFERENTIAL UBIQUITIN BINDING OF THE UBA DOMAINS FROM HUMAN JRNL TITL 2 C-CBL AND CBL-B: NMR STRUCTURAL AND BIOCHEMICAL INSIGHTS. JRNL REF PROTEIN SCI. 2008 JRNL REFN ESSN 1469-896X JRNL PMID 18596201 JRNL DOI 10.1110/PS.036384.108 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE REMARK 3 -KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ,RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES WERE CALCULATED WITH REMARK 3 ARIA/CNS USING TORSION ANGLE DYNAMICS REMARK 4 REMARK 4 2JUJ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-SEP-07. REMARK 100 THE DEPOSITION ID IS D_1000100307. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 20MM SODIUM PHOSPHATE, 50MM REMARK 210 SODIUM CHLORIDE, 1MM DTT, 90% REMARK 210 H2O, 10% D2O; 20MM SODIUM REMARK 210 PHOSPHATE, 50MM SODIUM CHLORIDE, REMARK 210 1MM DTT, 90% H2O, 10% D2O; 20MM REMARK 210 SODIUM PHOSPHATE, 50MM SODIUM REMARK 210 CHLORIDE, 1MM DTT, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D HNCO; 3D HNHA; 3D REMARK 210 HCCH-TOCSY; 3D 1H-15N NOESY; 3D REMARK 210 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : UNITY REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : 15 STRUCTURES FOR LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 2 92.41 49.93 REMARK 500 1 GLN A 32 54.09 39.71 REMARK 500 1 ILE A 35 -71.90 -73.32 REMARK 500 1 PHE A 45 -84.49 -101.27 REMARK 500 1 ALA A 52 88.24 62.07 REMARK 500 1 VAL A 54 31.88 -87.67 REMARK 500 2 THR A 2 139.95 -174.38 REMARK 500 2 PHE A 45 -75.67 -99.31 REMARK 500 2 SER A 49 34.28 -153.69 REMARK 500 2 HIS A 53 -149.53 -83.06 REMARK 500 2 VAL A 54 76.45 70.48 REMARK 500 3 PRO A 5 84.97 -46.36 REMARK 500 3 HIS A 53 136.18 75.84 REMARK 500 4 ALA A 3 -152.52 -78.46 REMARK 500 4 PHE A 45 -73.00 -93.84 REMARK 500 4 PRO A 51 -168.90 -67.39 REMARK 500 4 ALA A 52 -56.54 75.10 REMARK 500 4 ALA A 55 126.91 -172.81 REMARK 500 5 PRO A 5 -111.26 -93.43 REMARK 500 5 PHE A 45 -80.56 -106.48 REMARK 500 5 ALA A 55 79.92 -152.04 REMARK 500 6 ALA A 3 -78.87 -131.30 REMARK 500 6 ILE A 35 -70.60 -65.56 REMARK 500 6 PHE A 45 -80.68 -99.94 REMARK 500 7 GLN A 32 43.97 36.05 REMARK 500 7 PHE A 45 -79.80 -110.31 REMARK 500 7 ALA A 52 -56.59 69.15 REMARK 500 8 ALA A 3 88.68 -162.03 REMARK 500 8 PHE A 45 -75.17 -110.90 REMARK 500 9 THR A 2 47.14 -103.65 REMARK 500 9 PHE A 45 -79.37 -114.76 REMARK 500 9 SER A 49 51.54 -90.39 REMARK 500 10 ALA A 3 26.73 -147.64 REMARK 500 10 PRO A 5 -136.54 -79.06 REMARK 500 10 PHE A 45 -75.92 -116.16 REMARK 500 10 PRO A 51 48.47 -73.63 REMARK 500 11 PRO A 5 -8.82 -57.73 REMARK 500 11 PHE A 45 -71.58 -101.23 REMARK 500 11 ILE A 48 -159.60 -98.10 REMARK 500 11 ALA A 52 -86.53 65.75 REMARK 500 12 PHE A 45 -80.55 -100.38 REMARK 500 12 ALA A 52 -156.11 55.63 REMARK 500 12 ALA A 55 56.69 -105.86 REMARK 500 13 PHE A 45 -74.92 -97.88 REMARK 500 13 SER A 49 45.71 -87.70 REMARK 500 13 ALA A 52 -167.21 59.75 REMARK 500 13 HIS A 53 49.30 -161.29 REMARK 500 14 ALA A 3 174.73 64.81 REMARK 500 14 PHE A 45 -74.60 -95.34 REMARK 500 14 HIS A 53 74.86 35.75 REMARK 500 REMARK 500 THIS ENTRY HAS 55 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2JUJ A 1 56 UNP P22681 CBL_HUMAN 851 906 SEQRES 1 A 56 ALA THR ALA SER PRO GLN LEU SER SER GLU ILE GLU ASN SEQRES 2 A 56 LEU MET SER GLN GLY TYR SER TYR GLN ASP ILE GLN LYS SEQRES 3 A 56 ALA LEU VAL ILE ALA GLN ASN ASN ILE GLU MET ALA LYS SEQRES 4 A 56 ASN ILE LEU ARG GLU PHE VAL SER ILE SER SER PRO ALA SEQRES 5 A 56 HIS VAL ALA THR HELIX 1 1 SER A 4 SER A 16 1 13 HELIX 2 2 SER A 20 ALA A 31 1 12 HELIX 3 3 ILE A 35 PHE A 45 1 11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1